After a long gestation period, the so-called Italian Sunshine Act (Act) was finally approved in May 2022, setting forth provisions on transparency in relations between healthcare companies and government healthcare professionals (HCPs) and healthcare organizations (HCOs). It has taken almost three years for the Ministry of Health to share its expectations on how the Act will be effected. The implementation of the Act requires disclosure of many transactions involving HCPs and HCOs, introducing data privacy issues. In this guest article, Roberto Cursano, a partner at Studio Legale Delfino e Associati, Willkie, reviews the trend over the last decade toward increased government transparency in Italy and how it led to the passage of the Act, what the Act requires of companies and how companies should react. See “Takeaways From FTC’s Orders Targeting Digital Health Companies” (May 8, 2024).